Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03978039 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group

Study acronym: BCB-Sarcomes
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Publications: details revised at 3 of 3 entries
    • Eligibility criteria expanded, about 5 words
    v8
  2. Enrollment target: 20000 to 150000v7 Show 6 more changesShow less
    • Primary completion date: Dec 2025 to Dec 31, 2030
    • Study completion date: Dec 2030 to Dec 31, 2035
    • Start date: Jan 2010 to Jan 1, 2010
    • Publications: details revised at 3 of 3 entries
    • Study arms: 0 to 1
    • Eligibility criteria expanded, about 4 words
  3. Re-verified, no change to tracked fieldsv6
  4. Primary completion date: Dec 2021 to Dec 2025
    • Study completion date: Dec 2025 to Dec 2030
    v5
  5. Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Dec 2019 to Dec 2021v3
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Institut Bergonié
40 trials monitored
See 1 trial at risk
Sarcoma
1,026 trials monitored
See 67 trials at risk
The BCB SARCOMES database is a clinical and biological national database dedicated to sarcoma that contains 3 main databases with specific aims: the first is the pathology database (French expert network dedicated to the management of bone sarcomas \[RESOS\] / French expert network dedicated to the pathology of sarcomas \[RREPS\]), dedicated to systematic review of mesenchymal tumor diagnostics nationwide; the second is clinical (RESOS / French expert clinical network for sarcomas \[NETSARC\]), collecting multidisciplinary tumor boards (MDTB) data of patients nationwide, and the third (CONTICABASE / BONE / GIST) is dedicated to collecting patients longitudinal/follow up data, with a focus on treatments of every events, and a catalogue of associated samples. Primary objectives of BCB-SARCOMES are the following: description of the patterns of care and treatment outcomes, assessment of the prognostic factors of patients' outcomes. With the financial support of the French National Cancer Institute \[Institut National du cancer \[INCa\]).
Trial Details
NCT Number NCT03978039
Lead Sponsor Institut Bergonié
Collaborators: French Sarcoma Group
Conditions
(from sponsor)		 Sarcoma
Related terms Sarcoma
Enrollment 150,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov